Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
Rev. bras. hematol. hemoter
; Rev. bras. hematol. hemoter;38(4): 346-357, Oct.-Dec. 2016. tab
Article
в En
| LILACS
| ID: biblio-829948
Ответственная библиотека:
BR1.1
Локализация: BR408.1
ABSTRACT
ABSTRACT Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19+, CD5+ and CD23+. The lymphocytes usually infiltrate the bone marrow, peripheral blood, lymph nodes, and spleen. The diagnosis is established by immunophenotyping circulating B-lymphocytes, and prognosis is defined by two staging systems (Rai and Binet) established by physical examination and blood counts, as well as by several biological and genetic markers. In this update, we present the recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia for the diagnosis and treatment of chronic lymphocytic leukemia. The following recommendations are based on an extensive literature review with the aim of contributing to more uniform patient care in Brazil and possibly in other countries with a similar social-economic profile.
Key words
Полный текст:
1
База данных:
LILACS
Основная тема:
Prognosis
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Immunophenotyping
/
Cytogenetics
/
Neoplasm Staging
Тип исследования:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Страна как тема:
America do sul
/
Brasil
Язык:
En
Журнал:
Rev. bras. hematol. hemoter
/
Rev. bras. hematol. hemoter. (Online)
/
Revista brasileira de hematologia e hemoterapia (Impresso)
Тематика журнала:
HEMATOLOGIA
Год:
2016
Тип:
Article